Combining hormonal therapy and tirzepatide may lead to the greatest weight loss after menopause, new evidence suggests.

Combining tirzepatide, the medication sold as Zepbound and Mounjaro, with menopause hormone therapy, can increase weight loss ...

Weight gain is a common occurrence during menopause and often an unwelcome one. The extra pounds, which usually appear around the belly, can be especially hard to shed. Fortunately, the new wave of ...

Preclinical data suggest a possible synergistic interaction between estrogen and GLP-1 signaling, explains Regina Castaneda, MD. Midlife weight gain is a persistent challenge for many women, but ...

With menopause symptoms ranging from sleep trouble to burning mouth syndrome, people aren't always sure what they're experiencing. The Dose spoke to clinicians and researchers at the forefront of ...

When Jana Stewart, 54, a hormone and midlife health coach and bodybuilder, first hit perimenopause she was doing everything “right.” Between regular exercise and healthy eating, “I’d never had a ...

When Sarah Baldassaro turned 50, she took stock of her health and began working with a fitness coach on strength training, a type of exercise that's crucial for women in midlife.Related video above: ...

Most women expect the weight struggle to begin after menopause. But research suggests the real metabolic shift happens years earlier.

In postmenopausal women, combining menopausal hormone therapy with tirzepatide resulted in markedly greater weight loss than ...

You're in your mid-40s, eating healthy and exercising regularly. It's the same routine that has worked for years. Yet lately, the number on the scale is creeping up. Clothes fit differently. A bit of ...

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...